ROYSIA SURGERY — All Prescriptions & Medications — Page 9
Practice Code: E82132 | ROYSTON, SG8 5PT
Showing results 401-450 of 531
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Zolpidem tartrate | 19 | 700 | £30 | -78.9% ▼ |
| Lorazepam | 19 | 311 | £97 | -86.7% ▼ |
| Lisdexamfetamine dimesylate | 19 | 532 | £1.1K | -84.1% ▼ |
| Pioglitazone hydrochloride | 19 | 532 | £82 | -78.5% ▼ |
| Metronidazole | 19 | 760 | £78 | +187.3% ▲ |
| Mercaptopurine | 19 | 517 | £234 | +22.7% ▲ |
| Mefenamic acid | 19 | 856 | £164 | -57.9% ▼ |
| Tacrolimus | 19 | 810 | £618 | -64.8% ▼ |
| Bisacodyl | 18 | 635 | £34 | -86.3% ▼ |
| Glyceryl trinitrate | 18 | 540 | £673 | +35.5% ▲ |
| Dabigatran etexilate | 18 | 1,080 | £863 | -65.2% ▼ |
| Colesevelam hydrochloride | 18 | 3,240 | £1.2K | -52.6% ▼ |
| Combined ethinylestradiol 20mcg | 18 | 1,359 | £194 | -65.5% ▼ |
| Triptorelin | 18 | 18 | £3.4K | -14.7% ▼ |
| Calcitriol | 18 | 550 | £112 | +15.4% ▲ |
| Benzoyl peroxide | 18 | 750 | £130 | +27.7% ▲ |
| 18 | 2,281 | £94 | -78.9% ▼ | |
| 18 | 1,760 | £3.5K | -63.1% ▼ | |
| 18 | 205 | £522 | +23.3% ▲ | |
| 18 | 2,040 | £1.4K | -45.6% ▼ | |
| Levodopa/carbidopa/entacapone | 17 | 2,166 | £1.4K | -39.2% ▼ |
| Dutasteride | 17 | 510 | £29 | -66.9% ▼ |
| Ciprofloxain/dexameth | 17 | 85 | £99 | -44.6% ▼ |
| Liquid paraffin | 17 | 42.0K | £459 | +145.0% ▲ |
| Glycopyrronium bromide | 17 | 90 | £143 | -28.7% ▼ |
| Tetracaine | 17 | 42 | £31 | +94.1% ▲ |
| 17 | 770 | £3.3K | -23.8% ▼ | |
| 17 | 780 | £5.1K | +33.1% ▲ | |
| Codeine phosphate | 16 | 3,800 | £139 | +11.5% ▲ |
| Clomipramine hydrochloride | 16 | 427 | £87 | -62.0% ▼ |
| Pramipexole | 16 | 726 | £49 | -83.7% ▼ |
| Ofloxacin | 16 | 434 | £588 | +94.7% ▲ |
| Ibandronic acid | 16 | 22 | £23 | -56.0% ▼ |
| Denosumab | 16 | 16 | £2.9K | -41.2% ▼ |
| Other phosphate supplement preparations | 16 | 2,800 | £530 | +162.2% ▲ |
| Powder 1.6 kcal/ml milkshake (0913011) | 16 | 460 | £228 | -78.5% ▼ |
| Fusidic acid | 16 | 80 | £334 | +54.9% ▲ |
| 16 | 2,280 | £3.7K | -13.1% ▼ | |
| 16 | 543 | £1.9K | -59.9% ▼ | |
| 16 | 840 | £1.8K | -22.0% ▼ | |
| Umeclidinium bromide/vilanterol | 15 | 15 | £463 | -92.3% ▼ |
| Meptazinol hydrochloride | 15 | 1,512 | £284 | -54.6% ▼ |
| Almotriptan | 15 | 90 | £197 | +21.0% ▲ |
| Erythromycin | 15 | 536 | £197 | -56.7% ▼ |
| Medroxyprogesterone acetate | 15 | 939 | £187 | -60.8% ▼ |
| 15 | 825 | £81 | -69.7% ▼ | |
| Bezafibrate | 14 | 458 | £63 | -74.0% ▼ |
| Loprazolam mesilate | 14 | 784 | £622 | +5.8% ▲ |
| Doxylamine succinate/pyridoxine hydrochloride | 14 | 560 | £798 | +26.9% ▲ |
| Rizatriptan | 14 | 87 | £261 | -76.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.